Dr. Azad Kumar Singh, et al. “IMPACT OF TYPE 2 DIABETES MELLITUS ON RIFAMPICIN PHARMACOKINETICS AND BIOCHEMICAL PATHWAYS IN PULMONARY TUBERCULOSIS PATIENTS”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 32, no. 7, Aug. 2025, pp. 1149-53, https://doi.org/10.53555/gcv48408.